✨ Environmental and Health Notices
NEW ZEALAND GAZETTE
27 NOVEMBER
Environment
Resource Management Act 1991
The Resource Management (Approval of Waitaki Power Limited as Requiring Authority) Notice 1997
Pursuant to section 167 of the Resource Management Act 1991, the Minister for the Environment hereby gives the following notice:
N o t i c e
- Title and commencement—(1) This notice may be cited as the Resource Management (Approval of Waitaki Power Limited as Requiring Authority) Notice 1997.
(2) This notice shall come into force on the 28th day after the date of its publication in the New Zealand Gazette.
-
Interpretation—In this notice, unless the context otherwise requires, “line function services” has the meaning given to that term by section 2 of the Electricity Act 1992.
-
Approval as requiring authority—Waitaki Power Limited is hereby approved as a requiring authority under section 167 of the Resource Management Act 1991, for the supply of line function services.
Dated at Wellington this 17th day of November 1997.
HON. S. UPTON, Minister for the Environment.
g08579
Health
Medicines Act 1981
Corrigendum
Provisional Consent to the Distribution of a New Medicine
In the notice published in the New Zealand Gazette, 16 October 1997, No. 150, page 3517, notice No. 7417, amend the name of the active ingredient in the 7th line to donepezil hydrochloride.
Dated this 24th day of November 1997.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
g08596
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Alglucerase 10 U/mL, 80 U/mL in 5 mL | Solution, infusion, bottle | Genzyme Corporation, Cambridge, Massachusetts, United States of America | Ceredase |
| Note: This consent is valid for 2 years from the 30th day of November 1997. | |||
| 300 µg Anti D (Rh₀) immunoglobulin (> 820 IU) in 15 mL | Solution for IM injection, pre-filled syringe | Ortho Diagnostic Systems Inc., Raritan, New Jersey, United States of America | RhoGam |
| Note: This consent is valid for 2 years from the 16th day of May 1997. |
Conditions:
-
The health care professional who prescribes or administers RhoGam must report its use to CSL (New Zealand) Limited (Bioplasma) on a standardised form. The standardised form must contain the name and address of the health care professional and patient, and the reason, place and date of administration.
-
On a monthly basis, CSL (New Zealand) Limited (Bioplasma) are required to forward the user information forms to the Ministry of Health along with information detailing the amounts of RhoGam distributed and the sites to which it was distributed.
Dated this 24th day of November 1997.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
g08595
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1997, No 166
NZLII —
NZ Gazette 1997, No 166
✨ LLM interpretation of page content
Approval of Waitaki Power Limited as Requiring Authority
Environment17 November 1997
Resource Management Act, Requiring Authority, Waitaki Power Limited, Line Function Services
- HON. S. UPTON, Minister for the Environment
🏥 Corrigendum to Provisional Consent for New Medicine
🏥 Health & Social Welfare24 November 1997
Medicines Act, Provisional Consent, Donepezil Hydrochloride
- G. R. BOYD, Chief Advisor, Regulation and Safety
🏥 Renewal of Provisional Consent to Distribution of New Medicines
🏥 Health & Social Welfare24 November 1997
Medicines Act, Provisional Consent, Alglucerase, RhoGam, CSL (New Zealand) Limited (Bioplasma)
- G. R. BOYD, Chief Advisor, Regulation and Safety